Dual Mobile Total Hip Replacement in Super Obesity: A Case Report and Review of Literature.
Dual mobile total hip replacement
bariatric surgery
hip arthroplasty
morbid obesity
neck of femur fracture
revision hip arthroplasty
super obesity
Journal
Journal of orthopaedic case reports
ISSN: 2250-0685
Titre abrégé: J Orthop Case Rep
Pays: India
ID NLM: 101641392
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
26
06
2021
revised:
30
08
2021
entrez:
13
4
2022
pubmed:
14
4
2022
medline:
14
4
2022
Statut:
ppublish
Résumé
More than 13 million people in the US are morbidly obese. It is associated with various medical and anesthetic complications. Higher rate of dislocation in total hip replacement (THR) associated with morbid obesity due to thigh girth, low muscle mass and high-fat content. Morbid obesity is associated with a 38% increase in the 10-year mortality rate compare to non-obese after undergoing primary total hip arthroplasty (THA). Hip dislocation after THR is one of the earliest complications, and for every ten-point increase in BMI, the risk of dislocation increases by 113.9%. We present a case report of a 69-year-old super-obese woman with a BMI of 62.2, who presented with repeated dislocation post THR. The patient was managed successfully with implant removal and implantation of dual mobile THR prosthesis. Morbid obesity with a need for arthroplasty is challenging. It needs proper planning, thorough preoperative preparation, proper intraoperative care and identification with adequate post-operative complications management. Preoperative bariatric surgery, dual mobile liner and constrained implants have shown good result in decreasing dislocation rate. The liner of dual mobile THR is efficient to prevent post-operative dislocation in morbidly obese and super-obese patients.
Identifiants
pubmed: 35415086
doi: 10.13107/jocr.2021.v11.i10.2486
pii: JOCR-11-91
pmc: PMC8930310
doi:
Types de publication
Case Reports
Langues
eng
Pagination
91-95Informations de copyright
Copyright: © Indian Orthopaedic Research Group.
Déclaration de conflit d'intérêts
Conflict of Interest: Nil
Références
Eplasty. 2014 Apr 28;14:e20
pubmed: 24917894
J Am Acad Orthop Surg. 2017 Mar;25(3):188-194
pubmed: 28146438
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):318-321
pubmed: 30641719
J Arthroplasty. 2000 Dec;15(8):1003-8
pubmed: 11112195
Clin Orthop Relat Res. 2007 Dec;465:185-8
pubmed: 17906592
JAMA. 2004 Oct 13;292(14):1724-37
pubmed: 15479938
Clin Orthop Relat Res. 2016 Oct;474(10):2202-10
pubmed: 27130648
Arthritis Rheum. 2008 May 15;59(5):738-45
pubmed: 18438918
Clin Orthop Relat Res. 2013 Mar;471(3):971-80
pubmed: 22907474
J Arthroplasty. 2014 Oct;29(10):1899-905
pubmed: 25081511
Orthop Clin North Am. 2018 Jul;49(3):291-296
pubmed: 29929710
Int Orthop. 2017 Mar;41(3):469-473
pubmed: 27761631
Can J Surg. 2019 Dec 01;62(6):442-449
pubmed: 31782640
EFORT Open Rev. 2018 Sep 24;3(9):507-512
pubmed: 30305935
J Am Acad Orthop Surg. 2014 Nov;22(11):683-90
pubmed: 25344593
J Arthroplasty. 2005 Oct;20(7 Suppl 3):46-50
pubmed: 16214002